| Literature DB >> 33631128 |
Jamilah Meghji1, Kevin Mortimer2, Alvar Agusti3, Brian W Allwood4, Innes Asher5, Eric D Bateman6, Karen Bissell7, Charlotte E Bolton8, Andrew Bush9, Bartolome Celli10, Chen-Yuan Chiang11, Alvaro A Cruz12, Anh-Tuan Dinh-Xuan13, Asma El Sony14, Kwun M Fong15, Paula I Fujiwara16, Mina Gaga17, Luis Garcia-Marcos18, David M G Halpin19, John R Hurst20, Shamanthi Jayasooriya21, Ajay Kumar16, Maria V Lopez-Varela22, Refiloe Masekela23, Bertrand H Mbatchou Ngahane24, Maria Montes de Oca25, Neil Pearce26, Helen K Reddel27, Sundeep Salvi28, Sally J Singh29, Cherian Varghese30, Claus F Vogelmeier31, Paul Walker32, Heather J Zar33, Guy B Marks34.
Abstract
Low-income and middle-income countries (LMICs) bear a disproportionately high burden of the global morbidity and mortality caused by chronic respiratory diseases (CRDs), including asthma, chronic obstructive pulmonary disease, bronchiectasis, and post-tuberculosis lung disease. CRDs are strongly associated with poverty, infectious diseases, and other non-communicable diseases (NCDs), and contribute to complex multi-morbidity, with major consequences for the lives and livelihoods of those affected. The relevance of CRDs to health and socioeconomic wellbeing is expected to increase in the decades ahead, as life expectancies rise and the competing risks of early childhood mortality and infectious diseases plateau. As such, the World Health Organization has identified the prevention and control of NCDs as an urgent development issue and essential to the achievement of the Sustainable Development Goals by 2030. In this Review, we focus on CRDs in LMICs. We discuss the early life origins of CRDs; challenges in their prevention, diagnosis, and management in LMICs; and pathways to solutions to achieve true universal health coverage.Entities:
Year: 2021 PMID: 33631128 DOI: 10.1016/S0140-6736(21)00458-X
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321